A detailed history of Nisa Investment Advisors, LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 7,935 shares of IOVA stock, worth $46,895. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,935
Previous 8,309 4.5%
Holding current value
$46,895
Previous $78,000 25.64%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 17, 2025

SELL
$7.17 - $12.28 $2,681 - $4,592
-374 Reduced 4.5%
7,935 $58,000
Q3 2024

Oct 24, 2024

BUY
$7.28 - $11.9 $1,710 - $2,796
235 Added 2.91%
8,309 $78,000
Q2 2024

Jul 19, 2024

BUY
$7.78 - $14.19 $2,582 - $4,711
332 Added 4.29%
8,074 $64,000
Q1 2024

May 01, 2024

BUY
$7.59 - $17.47 $1,525 - $3,511
201 Added 2.67%
7,742 $114,000
Q4 2023

Jan 25, 2024

BUY
$3.3 - $8.89 $18,404 - $49,579
5,577 Added 283.96%
7,541 $61,000
Q3 2023

Nov 02, 2023

SELL
$4.44 - $8.79 $17,191 - $34,034
-3,872 Reduced 66.35%
1,964 $8,000
Q2 2023

Aug 11, 2023

BUY
$5.36 - $9.06 $10,532 - $17,802
1,965 Added 50.76%
5,836 $41,000
Q1 2023

May 02, 2023

BUY
$5.53 - $8.22 $11,032 - $16,398
1,995 Added 106.34%
3,871 $24,000
Q4 2022

Feb 02, 2023

SELL
$5.62 - $10.0 $25,638 - $45,620
-4,562 Reduced 70.86%
1,876 $12,000
Q3 2022

Nov 07, 2022

SELL
$9.53 - $13.11 $1,677 - $2,307
-176 Reduced 2.66%
6,438 $60,000
Q2 2022

Aug 03, 2022

BUY
$6.38 - $18.33 $39,492 - $113,462
6,190 Added 1459.91%
6,614 $73,000
Q4 2021

Feb 03, 2022

SELL
$16.55 - $27.63 $6,553 - $10,941
-396 Reduced 48.29%
424 $7,000
Q3 2021

Oct 18, 2021

SELL
$20.35 - $26.63 $112,922 - $147,769
-5,549 Reduced 87.13%
820 $20,000
Q4 2020

Jan 25, 2021

BUY
$28.04 - $50.26 $16,207 - $29,050
578 Added 9.98%
6,369 $296,000
Q3 2020

Oct 20, 2020

SELL
$27.75 - $36.3 $12,598 - $16,480
-454 Reduced 7.27%
5,791 $191,000
Q2 2020

Jul 27, 2020

BUY
$27.21 - $41.0 $146,498 - $220,744
5,384 Added 625.32%
6,245 $171,000
Q1 2020

Apr 17, 2020

BUY
$19.54 - $38.85 $3,126 - $6,216
160 Added 22.82%
861 $26,000
Q3 2019

Oct 17, 2019

SELL
$17.99 - $26.0 $4,479 - $6,474
-249 Reduced 26.21%
701 $13,000
Q1 2019

Apr 17, 2019

SELL
$8.41 - $11.26 $2,102 - $2,815
-250 Reduced 20.83%
950 $9,000
Q4 2018

Jan 17, 2019

BUY
$7.51 - $11.93 $5,181 - $8,231
690 Added 135.29%
1,200 $11,000
Q3 2018

Oct 16, 2018

SELL
$11.25 - $17.7 $2,137 - $3,363
-190 Reduced 27.14%
510 $6,000
Q1 2018

Apr 10, 2018

BUY
$8.1 - $19.5 $5,670 - $13,650
700 New
700 $12,000

Others Institutions Holding IOVA

About IOVANCE BIOTHERAPEUTICS, INC.


  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $933M
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.